Michael J. Rider - Jun 2, 2025 Form 4 Insider Report for RESMED INC (RMD)

Signature
Michael J. Rider, Global General Counsel and Secretary
Stock symbol
RMD
Transactions as of
Jun 2, 2025
Transactions value $
-$75,414
Form type
4
Date filed
6/3/2025, 01:13 PM
Previous filing
Apr 3, 2025
Next filing
Jul 2, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rider Michael J Global General Counsel 9001 SPECTRUM CENTER BLVD, SAN DIEGO Michael J. Rider, Global General Counsel and Secretary 2025-06-03 0001982205

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$9.99K -41 -0.46% $243.78 8.87K Jun 2, 2025 Direct F1, F2
transaction RMD ResMed Common Stock Tax liability -$65.4K -267 -3.01% $244.79 8.6K Jun 2, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.
F2 Includes 64.6438 shares of ResMed stock purchased on April 30, 2025, through the ResMed Employee Stock Purchase Plan.
F3 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.